Home Health News UPDATED: AstraZeneca, Oxford researchers champion a one-two punch against Covid-19 in first human study – Endpoints News

UPDATED: AstraZeneca, Oxford researchers champion a one-two punch against Covid-19 in first human study – Endpoints News

1 min read
0
0
94

[ad_1]

The biotech and infectious disease world — much of the world, really — sat eagerly anticipating the early Covid-19 vaccine data AstraZeneca and the Lancet had promised would emerge on Monday. Then, at 9:30 EST, the Lancet posted not only the AstraZeneca data but a second batch of important results: the Phase II data from Chinese biotech CanSino Biologics.

AstraZeneca, Moderna and Pfizer, among others, have captured much of the attention in Europe and North America, where countries have helped usher the vaccines through trials and signed deals for hundreds of millions of doses. But CanSino was the first of any effort to report Phase I data and they’ve rolled along at the front of the pack since.

Endpoints News

Keep reading Endpoints with a free subscription

Unlock this story instantly and join 85,500+ biopharma pros reading Endpoints daily — and it’s free.


Let’s block ads! (Why?)

[ad_2]
Source link

Load More Related Articles
Load More By admin
Load More In Health News

Leave a Reply

Your email address will not be published. Required fields are marked *

Check Also

UK coronavirus variant cases doubling every 10 days in US, study finds – Fox News

[ad_1] The highly-contagious COVID-19 variant first detected in the United Kingdom is now …